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Abstract
This report presents the findings of the ninth survey on trends in industrial R&D investment. It analyses the 186 responses of 
mainly large firms from a subsample of 1000 EU-based companies in the 2013 EU Industrial R&D Investment Scoreboard. 
These 186 companies are responsible for R&D investment worth almost €60 billion, constituting around 36% of the total R&D 
investment by the 1000 EU Scoreboard companies.
The main conclusion is that the responding companies expect R&D investment to increase by on average 4.2 % per year during 
2014–16. This is about 50 % higher than the increase anticipated in the previous survey (2.6 %) and mainly reflects the shift in 
expectations in the automobiles and parts sector, which returns to the level of previous years (4.6 %) after last year’s reported 
stagnation (–0.4 %). 
The responding companies carry out one fifth of their R&D outside the EU. The responding companies’ expectations for R&D 
investment for the next three years show the ongoing participation of European companies in the global economy. While 
maintaining the focus of their R&D investment in the EU, they reap opportunities for growth in emerging economies. Two out 
of three of the responding EU-based companies consider their home country the most attractive location for R&D. The United 
States, Germany, China and India are the most attractive locations mentioned outside the home country.
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The present document contains the main findings of the 
ninth European Commission survey on industrial research 
and development (R&D) investment trends. It analyses 
the responses of 186 mainly very large enterprises from 
a subsample of 1 000 EU-based companies in the 2013 
EU Industrial R&D Investment Scoreboard1.  These 186 
companies invested almost € 60 billion in R&D from their 
own resources, which corresponds to 36 % of the total R&D 
investment by the 1 000 EU Scoreboard companies. The 
main findings of the survey are as follows. 
 
R&D investment expectations 
The responding companies expect R&D investment 
to increase by on average 4.2 % per year during 
2014–16. This is about 50 % higher than the increase 
anticipated in the previous survey (2.6 %) and mainly 
reflects the shift in expectations in the automobiles 
1 These are 527 EU-based companies of the world top 2 000 companies in the 2013 
Scoreboard and 473 additional from the EU with an R&D investment of over € 5.2 
million in the accounting period  2012/13.
and parts sector, which returns to the level of previous 
years (4.6 %) after last year’s reported stagnation 
(–0.4 %).   
The increase in R&D investment is higher than in the past in 
the following sectors: aerospace and defence (7.8 % per year 
over the next three years); healthcare equipment and services 
(6.4 %); and fixed-line telecommunications (4.0 %). In other 
sectors, the expected increases in R&D investment are lower 
than in previous surveys: general industrials (5.6 % per year 
over the next three years); construction and materials (3.2 
%); chemicals (2.9 %); and industrial engineering (0.9 %). 
The two sectors pharmaceuticals and biotechnology and 
automobiles and parts, which constitute more than 20 
% of the total sample R&D each, expect similar levels of 
increase in R&D investment (4.4 % and 4.6 %, respectively). 
For automobiles and parts, the 4.6 % increase represents a 
significant shift from the expected stagnation declared in the 
2013 survey (–0.4 %).  
Executive Summary
Figure 1: Expected changes of R&D investment of the surveyed companies 2014-16, p.a. 
Note: p.a. per annum
European Commission JRC-IPTS (2014) 
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Key Enabling Technologies 
(KETs)
Activities related to Key Enabling Technologies (KETs) 
are highly diverse and often concentrated among 
few companies, mainly from high and medium R&D-
intensity sectors. 
127 responding companies have detailed the technological 
profile of their R&D investments in KETs and related 
technological fields. The highest share concerns socially or 
environmentally relevant technologies (38 %). The five core-
KETs (advanced materials, industrial biotechnology, micro- and 
nanoelectronics, nanotechnology and photonics) constitute 
9 % of their R&D, and Advanced Manufacturing Techniques 
(AMTEC) 4 %. Most of the R&D for the five core-KETs comes 
from companies in the high R&D-intensity sector, and most 
of the R&D for AMTEC from the medium R&D intensity ones. 
The high and medium R&D-intensity companies also spend 
the lion’s share of R&D in social or environmentally relevant 
technologies. 
The total number of patents filed in KETs increases 
with the R&D-intensity of the sector group. The highest 
technological diversity of patents filed can be found in 
the medium R&D-intensity sectors.
Revenues from and expenses for licences are mainly 
concentrated in companies from the high R&D-intensity 
sector and in the field of red and green biotechnology (which 
constitutes over two thirds of the total for both revenue 
and expenses). High R&D-intensity firms report investments 
in all the surveyed KETs, with a focus on red and green 
biotechnology and key software technologies. For companies 
from the medium and low R&D-intensity sectors, the majority 
of investments are concentrated in key software technologies.
  
Figure 2: R&D investment in KETS and other relevant technologies
Note:   The figure refers to 127 out of the 186 EU companies in the sample 
Source:  European Commission JRC-IPTS (2014) 
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Location of R&D investment
The 166 companies which provided information make 
one-fifth of their R&D outside the EU.
The largest share of R&D investment made outside the EU is 
in the United States and Canada (8.4 %), followed by China 
(4.3 %), the rest of the world (3.6 %), India (1.9 %), other 
European countries (1.6 %) and Japan (1.2 %). 
The responding companies’ expectations for R&D 
investment for the next three years show the ongoing 
participation of European companies in the global 
economy. While maintaining the focus of their R&D 
investment in the EU, they reap opportunities for 
growth in emerging economies. 
Examining the distribution of the expected 4.2 % R&D 
increases by world region, moderate but sustained growth 
is expected in R&D investment in the EU (3.1 % per year 
over the next three years). This contrasts with much higher 
expectations for investment growth in non-EU world regions: 
India (11.9 %); China (8.7 %); the United States and Canada 
(8.1 %); and the rest of the world (7.2 %). Expectations for 
Japan and other European countries lie at around 1 % or 
below and are combined with a relatively small share of 
total R&D investment. All in all, the expected nominal R&D 
investment increases in the EU continue to be of a similar 
magnitude to those outside the EU (around € 900 million 
per year for a total of 151 companies which provided 
information). 
Country attractiveness for R&D
Two out of three of the responding EU-based companies 
consider their home country the most attractive 
location for R&D. The United States, Germany, China 
and India are the most attractive locations mentioned 
outside the home country.
Finland and Denmark were mentioned only by respondents 
for which they are the home country. The Netherlands, 
Poland and Romania are EU countries with an especially high 
attractiveness index for companies for which they are not 
the home country. 
Human resources, knowledge-sharing and proximity 
to other company sites are the criteria that make 
countries attractive for R&D activity. 
For the countries where companies have the greatest 
R&D activity, the criteria most influencing attractiveness 
were said to be R&D personnel in the labour market 
(quality, quantity and labour costs), knowledge-sharing and 
collaboration opportunities (with universities and public 
research organisations) and proximity (to other company 
sites, technology poles and incubators, and suppliers). 
In a separate comparison of attractiveness factors 
among R&D sites within the EU, quality of R&D 
personnel and knowledge-sharing opportunities with 
universities and public organisations are by far the 
most frequently stated in the top three.
They are followed by proximity to other company sites 
(for Belgium, Denmark, Germany, France, Italy, Finland 
and Sweden) and quantity of R&D personnel (for Italy, 
Austria, Poland and the United Kingdom). The factors that 
make countries less attractive are related to demand for 
innovation via market growth (for Denmark, Spain, Italy, the 
Netherlands, Austria and Sweden) and public procurement 
(for Belgium, France and the United Kingdom). 
Comparing R&D attractiveness factors within the EU 
with those for the United States, the 38 respondents 
point to knowledge-sharing opportunities and quality 
and quantity of R&D personnel as the leading factors 
for both world regions.
Proximity to technology poles and incubators, other company 
sites and suppliers is also mentioned as an important factor 
for the attractiveness of R&D sites in both regions. As in our 
previous survey, the respondents consider the United States 
more attractive for R&D than the EU regarding market size 
and growth, whereas the quality of R&D personnel in the 
labour market and public support for R&D via grants and 
direct funding and fiscal incentives stood out in EU countries. 
Comparing R&D attractiveness factors within the EU 
with those for China and India, the 13 respondents 
reveal significant differences between the two world 
areas.
For R&D sites in the EU, the quality of R&D personnel, 
knowledge-sharing opportunities (with universities and 
public organisations and other firms) and proximity (to 
other company sites, technology poles and incubators, and 
suppliers) are the most relevant factors. 
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For R&D sites in China and India, market size and growth, 
together with the quantity and labour cost of R&D personnel, 
are the main determinants of attractiveness. Compared with 
the EU, China and India are not attractive in terms of either 
intellectual property rights (IPR), especially enforcement 
conditions, or public support for R&D via grants and direct 
funding, public–private partnerships and financing of other 
(non-R&D) investments.
 
R&D and innovation 
R&D within the company is the most important 
component of innovation, followed by market 
research, product demonstration and training to 
support innovation activities.
As observed in our previous surveys, and not surprisingly 
for major R&D players, internal R&D is critical for innovation 
(for more than 97 % of respondents). Market research is 
the second most relevant component, followed by product 
demonstration and training. The purchase or licensing of IPR 
is the least important aspect. However, the importance of 
these factors varies significantly between firms in sectors 
with high, medium or low R&D intensity and also depending 
on whether the R&D is performed within or outside the EU
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Investment in research and innovation is one of the five main 
targets of Europe 2020, the EU’s 10-year growth strategy.2 
Its aim is not only to overcome the crisis that continues in 
many EU economies but also to address the shortcomings 
in its growth model and create conditions favourable for a 
type of growth that is smarter, more sustainable and more 
inclusive.
Five key targets have been set for the EU to achieve by the 
end of the decade in the areas of employment, education, 
research and innovation, social inclusion and poverty 
reduction, and climate/energy. In practical terms, this 
includes seven ‘flagship initiatives’, providing a framework 
through which the EU and national authorities can mutually 
reinforce their efforts in areas supporting Europe 2020. One 
of them is the Innovation Union flagship initiative,3 which 
includes a 3 % EU headline target for intensity of research 
and development (R&D) investment.4 R&D investment from 
the private sector, however, plays a key role not only for the 
Innovation Union flagship initiative but also for other relevant 
Europe 2020 initiatives, such as the Industrial Policy,5 Digital 
Agenda and New Skills for New Jobs flagship initiatives. 
The Industrial Research and Innovation Monitoring 
and Analysis (IRIMA) project6 supports policymakers in 
these initiatives and monitors progress towards the 3 % 
headline target. IRIMA’s core activity is the EU Industrial 
R&D Investment Scoreboard,7 which analyses private 
2  European Commission, Europe 2020: a strategy for smart, sustainable and 
inclusive growth (see: http://ec.europa.eu/eu2020/index_en.htm).
3  The Innovation Union flagship initiative aims to strengthen knowledge and 
innovation as drivers of future growth by refocusing R&D and innovation policies for 
the main challenges society faces.
4  This target refers to the EU’s overall (public and private) R&D investment 
approaching 3 % of gross domestic product (see: http://ec.europa.eu/europe2020/pdf/
targets_en.pdf).
5  The Industrial Policy for the Globalisation Era flagship initiative aims to improve 
the business environment, notably for small and medium-sized enterprises, and 
support the development of a strong and sustainable industrial foundation for global 
competition.
6  See: http://iri.jrc.ec.europa.eu/. The activity is undertaken jointly by the Directorate 
General for Research (DG RTD C; see: http://ec.europa.eu/research/index.cfm?lg=en) and 
the Joint Research Centre, Institute for Prospective Technological Studies (JRC-IPTS; 
see: http://ipts.jrc.ec.europa.eu/activities/research-and-innovation/iri.cfm). 
7  The Scoreboard is published annually and provides data and analysis on companies 
from the EU and abroad investing the largest sums in R&D (see: http://iri.jrc.ec.europa.
eu/scoreboard.html).
R&D investments based on the audited annual accounts 
of companies and shows ex-post trends. By collecting 
expectations and qualitative statements from the EU 
Scoreboard companies, the present survey complements the 
Scoreboard with ex-ante information. 
The European Commission has undertaken eight previous 
surveys since 2005.8 Similar to its predecessors, the present 
survey addresses the R&D investment expectations for 
2014-16, R&D location strategies and the relationship 
between R&D and innovation. A new element of the current 
edition of the survey is the question on the role of certain 
key enabling technologies (KETs) in the development of new 
goods and services.9 
‘R&D investment’, in our surveys, refers to the total amount 
of R&D financed by the company, regardless of where or 
by whom it was performed. This excludes R&D financed by 
governments or other companies, as well as the company’s 
share of any associated company or joint venture R&D 
investment. It includes, however, research contracted out 
to other companies or public research organisations, such 
as universities. The survey reports what each responding 
company states as its actual financial commitment to R&D. 
This is different from the official statistical concept, business 
expenditure on R&D (BERD), which provides a geographical 
perspective.10
The questionnaire was sent by post to the top operational 
level (chief executive officer or similar) or previous year’s 
contact person of the 1 000 European companies that appear 
in the 2013 EU Industrial R&D Investment Scoreboard. A total 
of 186 responses, equivalent to a response rate of 18.6 %,11 
were received. These 186 companies are responsible for a 
total global R&D investment of almost € 60 billion, which 
corresponds to 36 % of the total R&D investment by the 
1 000 EU Scoreboard companies. 
8  See: http://iri.jrc.ec.europa.eu/survey.html 
9  See section 3. 
10  BERD includes R&D financed by the company itself, as well as R&D performed by 
a company but funded from other sources. Official BERD figures comprise R&D carried 
out by the companies physically located in a given country or region (including foreign-
owned subsidiaries), regardless of the source of funding.
11  See Annex A: The Methodology of the 2014 Survey.
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The number of responses received by sector group and the 
corresponding share of R&D compared with the 1 000 EU 
Scoreboard companies are summarised in Table 1.12 
Companies in the sector group with medium R&D intensity 
are responsible for the majority of R&D investment and 
constitute the majority of respondents in the sample. 
Although an emphasis on the sectors with medium R&D 
12  R&D intensity is the ratio between R&D investment and net sales. An individual 
company may invest a large overall amount in R&D but have a low R&D intensity if 
net sales are high (as is the case of many oil & gas producers, for example). For the 
groupings see: Annex A: The Methodology of the 2014 Survey.
intensity was also observed in last year’s survey, their share 
of this year’s sample is much higher compared with the R&D 
investment composition of the 2013 Scoreboard (Figure 
3). This is due to an over-representation of companies 
from the automobiles and parts, chemicals, and fixed-line 
telecommunications sectors in the sample. 
Table 1: Number of responses, by sector group
Sector Group ICB Sector Number of responses
R&D share of the 
sample of the 1000 
EU Scoreboard 
companies
High R&D 
intensity
Pharmaceuticals & Biotechnology, Software & Computer Services, 
Aerospace & Defence, Technology Hardware & Equipment and 
Health Care Equipment & Services
58 26%
Medium R&D 
intensity
Industrial Engineering, Chemicals, Electronic & Electrical 
Equipment, Automobiles & Parts, Food Producers, General 
Industrials, Fixed Line Telecommunications, Household Goods & 
Home Construction, Support Services, Media and Personal Goods
88 47%
Low R&D 
intensity
Construction & Materials, Industrial Metals & Mining, Banks, 
Electricity, Oil & Gas Producers, Gas, Water & Multi-utilities, 
Forestry & Paper, Mining, and Mobile Telecommunications.
40 32%
186 36%
Source:  European Commission JRC-IPTS (2014)
Figure 3: Distribution of R&D investment in the survey compared to the 2013 Scoreboard
Note: The figure refers to all 172 companies in the sample.
Source: European Commission JRC-IPTS (2014)
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As in our previous surveys, the participating companies are 
very large, with an average turnover of € 13 billion, 34 000 
employees in total and 1 650 employees engaged in R&D. In 
the sample, there are only seven medium-sized companies 
and one small company (mainly in the sectors with high R&D 
intensity). Among the large companies in the sample, 23 
had between 251 and 1 000 employees, 71 between 1 001 
and 10 000 employees, 42 between 10 001 and 30 000 
employees, and 42 more than 30 000 employees.
It follows that the survey differs from the Community 
Innovation Survey (CIS), which uses a different sampling 
technique, taking in a much higher number of small and 
medium-sized firms.13 
As in our previous surveys, the response rate of previous 
participants was close to 50 %.14
13  The CIS uses stratified sampling for at least three size classes (small, medium and 
large enterprises) across all EU Member States.
14  Out of the 186 responding companies, 90 had participated in the previous two 
surveys (in 2012, 91 out of 172), 67 in the previous three, 50 in the previous four, 35 
in the previous five, 21 in the previous six, 15 in the previous seven, 10 in the previous 
eight, and six in all nine surveys. 
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The responding companies expect to increase their R&D 
investment by 4.2 % per year during 2014–16.15 This is 
similar to the results of our 2013 survey (without the 
automobiles and parts sector) and the one before. 
This 4.2 % annual growth in corporate R&D investment is a 
positive outlook, above the nominal EU growth estimates for 
gross domestic product (GDP) of 1.6 % for 2014 and 2.0 % 
for 2015.16 However, R&D investment expectations are still 
15  The expectations are per annum over the next three years, weighted by R&D 
investment. 
16  European Commission, ‘Spring 2014 economic forecast: growth becoming 
broader-based’ (see: http://ec.europa.eu/economy_finance/eu/forecasts/2014_spring/
overview_en.pdf).
far from the levels reported prior to the 2008 economic crisis 
(7 % in the 2007 survey). The biggest expectations are found 
in companies with high R&D intensity (5.2 %), followed by 
those with medium (4.0 %) and low R&D intensity (2.1 %; 
see Figure 4 below). 
Figure 5 compares the respondents’ expected changes in 
R&D investment in 2014–16 with their expectations for 
2013–15 and 2012–14 in our two previous surveys.17 
17  The samples in the different surveys have different compositions.
2 R&D Investment Expectations
Figure 4: Expected changes in R&D investment in the next three years, per annum, in real terms
Note: The figure refers to 162 out of the 186 companies in the sample, weighted by R&D investment.
Source: European Commission JRC-IPTS (2014)
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The expected increase in R&D investment is significantly 
higher than in our previous surveys in the following sectors: 
aerospace and defence (7.8 % per year over the next three 
years); healthcare equipment and services (6.4 %); and 
fixed-line telecommunications (4.0 %). In the group with 
high R&D intensity, expected R&D investment increases in 
pharmaceuticals and biotechnology (4.4 %) and technology 
hardware and equipment (3.6 %) are slightly above those of 
last year’s survey but below those of two years ago. 
In other sectors, the expected increases in R&D investment 
are lower than in our previous surveys: general industrials 
(5.6 % per year over the next three years); construction 
and materials (3.2 %); chemicals (2.9 %); and industrial 
engineering (0.9 %). 
The two sectors pharmaceuticals and biotechnology and 
automobiles and parts each constitute more than 20 % of 
the total sample investment in R&D, so their expectations are 
very important for the whole sample. The expected increase 
in R&D investment in pharmaceuticals and biotechnology is 
similar to that reported in our past surveys (4.6 %). 
R&D investment expectations in the automobiles & parts 
sector increased to 4.6 %. The stagnation in investment in 
R&D in that sector observed in the 2012 survey was not 
detected in the present exercise. This may be because the 
drop in passenger vehicle sales forecast in 2012 for 2013 
did not materialise,18 and expectations for 2014 have 
18  Center of Automotive Management (CAM), ‘PKW Absatzzahlen im Kalenderjahr 
2013’ (see: http://www.auto-institut.de/index_htm_files/Absatz%20OEM%2012_13.
jpg).
Figure 5: Expected changes in R&D investment in the current and previous two surveys, p.a.
Note: p.a. per annum
* The sample compositions in all three surveys vary from year to year. Growth rates calculated as CAGR over the three years for which 
expectations were mentioned (see Annex A: The Methodology of the 2014 Survey). 
The figure refers to 140 out of the 186 companies in the sample, weighted by R&D investment. Only for sectors with at least five responses. 
Source: European Commission JRC-IPTS (2014)
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even improved.19 R&D investment expectations for the 
automobiles & parts sector are thus back to a level similar 
to those reported in previous years. 
The 2014 forecast figure for the increase in R&D funded and 
performed by US companies is the same as that reported 
here by the EU companies surveyed (4.2 %).20 These 
figures, higher than last year’s expectations, correspond to 
a somewhat improved general economic and business cycle 
outlook.21 
The R&D investment growth expectations collected in our 
surveys are compared with the R&D investment trends 
observed in the Scoreboard (Figure 6).  
19  Center of Automotive Management (CAM), ‘Forecast of global passenger vehicle 
sales for 2014’ (see: http://www.auto-institut.de/index_htm_files/prognoseabs2014.
jpg).
20  ‘The Battelle 2014 Global R&D Funding Forecast’, R&D Magazine, December 2013 
(see: http://battelle.org/media/press-releases/2014-global-funding-forecast). Battelle’s 
estimates refer to R&D funding, which has a definition slightly different from that of 
R&D investment, as given here. 
21  ‘The Industrial Research Institute’s 2014 R&D Trends Forecast’, Research-
Technology Management, January–February 2014 (see http://www.iriweb.org/Public_
Site/RTM/Volume_57_Year_2014/January-February_2014/2014_IRI_Trends_Forecast.
aspx). This forecast is based on a survey of 107 US-based companies and indicates a 
stagnation in R&D in these companies owing to the challenging business landscape. 
The abovementioned forecast by Battelle and the present survey show more 
optimistic expectations for R&D, which seem to be the result of an improved economic 
environment, which is also observed in the official GDP estimates. The responses for 
the Industrial Research Institute’s forecast were collected eight months before ours 
and a few months before the Battelle study. 
The trends of the R&D investment expectations reported 
in our surveys before 2013 were largely in line with the 
actual follow-up trends observed in the Scoreboards. The 
trends anticipated by the Survey in 2013 and 2014 were 
different from the Scoreboard due to differences in sample 
composition. The 2013 Survey expectations were especially 
low due to the weight of the slightly negative expectations 
for the automobile & parts sector. Without this sector, the 
expectations were at a similar level than those of 2012 and 
2014 and thus much closer to the figures observed in the 
Scoreboard. 
Figure 6: Expected (survey) versus observed (Scoreboard) R&D growth
Note:  * Survey annual growth expectations are for the next three years following the exercise, while the Scoreboards refer to the latest audited 
accounts. The figure refers to 163 out of the 186 companies in the 2014 survey sample, weighted by R&D investment.
Source: European Commission JRC-IPTS (2014)
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The Commission is undertaking initiatives to strengthen KETs 
for the development of new goods and services.22 In order 
to gain a better understanding of companies’ perspectives 
on KETs and their relationship with other important 
technologies, a typology of technological fields was provided 
in the questionnaire. It includes the five core KETs:23
1. Advanced materials leading to lower-cost substitutes 
of existing materials and new higher value-added 
products & services;
2. Industrial (white) biotechnology applied to industrial 
processing and production of chemicals, materials and 
fuels;
3. Micro- and nanoelectronics, e.g. semiconductor 
components and highly miniaturised electronics,
4. Nanotechnology, i.e. design, production and application 
of structures, devices and systems by controlling shape 
& size at nanometric scale; and
5. Photonics, i.e. conversion of sunlight into electricity, 
photodiodes, LEDs and lasers.
A further category was added for a range of advanced 
manufacturing technologies identified as critical in the 2012 
Industrial Policy Communication:24 
22  These KETs enable the development of new goods and services and the 
restructuring of industrial processes needed to modernise EU industry and make 
the transition to a knowledge-based and resource-efficient economy. While the EU 
has very good R&D capacities in some KETs, it has not always been successful in 
translating research results into commercialised manufactured goods and services. 
The Commission’s KET strategy aims to boost the industrial production of innovative 
KET-based products and applications in the future (see: http://ec.europa.eu/enterprise/
sectors/ict/key_technologies/). 
23  According to section 2 of the Staff Working Document (see: http://ec.europa.eu/
enterprise/sectors/ict/files/staff_working_document_key_enabling_technologies_
en.pdf).
24  The European Commission’s 2012 Industrial Policy Communication (see: http://
eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=COM:2012:0582:FIN:EN:PDF) aims to 
boost the contribution to GDP of industry in Europe from its current level of around 
16 % to 20 % by 2020. To achieve this ambitious target, the European Commission 
has engaged in a partnership with the Member States and industry to step up efforts 
to boost the market uptake of European AMTECs and give Europe a competitive lead 
in the new industrial revolution (see: http://ec.europa.eu/enterprise/policies/industrial-
competitiveness/industrial-policy/task-forces/amt/index_en.htm).
6. Advanced Manufacturing Technologies (AMTEC) 
encompass the use of innovative technology to improve 
products or processes that drive innovation, including all 
production equipment that deploys a KET or any other 
innovative technology.
Another three categories were added in order to consider 
related and socially or environmentally relevant technologies:
7. Other (red and green) biotechnology applied to 
medical and agricultural processes;
8. Environmental technologies (incl. alternative 
energy), i.e. devices, materials, and techniques for 
pollution prevention, reduction or containment, and
9. Key software technologies, e.g. high performance 
computing, building data value, social computing, 
internet-based applications, embedded systems, human-
centred computing, enterprise applications and the 
generation of software-intensive systems.25 
Free space was provided for the respondents to name other 
technologies especially relevant for the company not 
covered in the above classification. 
The respondents were asked to estimate the approximate 
numbers of patents filed, the revenue from licences issued, 
the expenditure on licences used and the amount of R&D for 
each technological field in the past year (2013, in €).
25  According to the 2012 ISTAG report: http://cordis.europa.eu/fp7/ict/docs/istag-soft-
tech-wgreport2012.pdf.
3 Key Enabling Technologies (KETs)
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Technological content of R&D 
by technology group
Out of the 186 respondents, 127 companies provided 
details about the technological content of their R&D 
investment according to the above categories. As 
shown in Figure 7 below by technology group, the 
highest share concerns socially or environmentally 
relevant technologies (38 %), followed by other 
technologies especially relevant for the company (23 
%), the five core-KETs (9 %) and AMTEC (4 %). About 
one quarter corresponds to other R&D not further 
specified.
Most of the R&D for the five core-KETs comes from 
companies in the high R&D-intensity sector, and most of 
the R&D for AMTEC from the medium R&D intensity ones. 
The high and medium R&D-intensity companies also spend 
the lion’s share of R&D in social or environmentally relevant 
technologies. 
Technologies especially relevant for the company concern 
sector-specific technological fields and were mentioned 
mainly for the high R&D intensity sectors (33 %, mainly 
health and aerospace & defence-related technologies), 
followed by the medium R&D-intensity sectors (16 %, mainly 
chemicals and electronic and electrical equipment related) 
and the low R&D-intensity sectors (8 %, mainly related to oil 
& gas producers).
Figure 7: R&D investment in KETS and other relevant technologies
Note:  The figure refers to 127 out of the 186 EU companies in the sample.
Source:  European Commission JRC-IPTS (2014)
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Technological content of R&D 
by technology field in detail
Figure 8 examines the technological fields in the above 
groups in more detail. The majority of R&D is invested in 
key software technologies (46 % of the total reported) and 
other (red and green) biotechnology (24 %). Very few R&D 
resources are invested in photonics and nanotechnology 
(below 1% each). 
High R&D-intensity firms report investments in all the 
surveyed KETs, but mainly in other (red and green) 
biotechnology (55 % of the total reported R&D investments 
in KETs) and key software technologies (46 %). For the other 
two groups, the majority of investments are concentrated in 
key software technologies. This corresponds to the fact that 
the three sectors at ICB4 digit level investing more in R&D 
for KETS are pharmaceuticals, fixed line telecommunications 
and banks.26 
Per company, high R&D-intensity firms invest more (€ 131 
million per firm on average) in KETs than medium and low 
R&D-intensity firms (€ 89 and € 77 million, respectively). 
However, the difference between the three groups is not as 
marked as it is in the case of revenue from and expenses 
for KETs license (see Figure 13 and Figure 14 further below).
 
26  Looking at the concentration of the investments in KETs at firm level, overall the 
value of HHI and C4 are quite low (HHI=0.072, C4=0.464).The situation differs if we 
look at R&D intensity group level. While among the medium R&D intensity firm the 
concentration is still fairly low (HHI=0.072, C4=0.464), investments in R&D for KETs 
are more concentrated in the case of high (HHI=0.258, C4=0.812) and low (HHI=0.272, 
C4=0.874) R&D intensity firms.
Figure 8: R&D investment in KETS - detailed
Note: The figure refers to 118 out of the 186 EU companies in the sample. 
Source: European Commission JRC-IPTS (2014)
T h e  2 0 1 4  E U  S u r v e y  o n  R & D  I n v e s t m e n t  B u s i n e s s  T r e n d s
20
Number of patents 
Figure 9 compares the number of patents filed by responding 
companies in technology group. Patents in the five core-KETs, 
AMTEC and socially or economically relevant technologies 
account for almost half the total patents filed by high R&D-
intensity firms. For medium and low R&D-intensity firms 
this percentage is considerably smaller (21 % and 37 %, 
respectively).
For every technological group, more patents are reported 
in the five core-KETs than in the socially or economically 
relevant technologies.
Figure 10 focuses on the patents by technology field in detail 
within the technological groups.
Figure 9: Number of patents filed by technological group
Note: The figure refers to 132 out of the 186 EU companies in the sample. 
Source: European Commission JRC-IPTS (2014)
Figure 10: Number of KETs patents filed - detailed
Note: The figure refers to 118 out of the 186 EU companies in the sample. 
Source:European Commission JRC-IPTS (2014)
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On average, the high R&D-intensity companies filed a higher 
number of KETs patents (3268) than medium and low 
R&D-intensity firms (2570 and 879, respectively). Overall, 
the technology category with the majority of reported filed 
patents is micro and nanoelectronics (1864), followed by 
advanced materials (1666). In comparison, only 156 and 53 
patents have been reported in photonics and nanotechnology. 
A closer look at the three R&D-intensity groups shows a 
similar behaviour of high and low R&D-intensity firms. Almost 
three quarters of the filed patents are concentrated within 2 
sectors:  micro and nanoelectronics and advanced materials 
for the high R&D-intensity firms (combined share 72 %), and 
advanced materials and key software technologies for the 
low R&D-intensity firms (combined share 79 %). Medium 
R&D-intensity firms show a more diversified behaviour, 
with more than 10 % each of patents spread over five 
of the nine technologies surveyed (advanced materials, 
industrial (white) biotechnology, advanced manufacturing 
technologies, environmental technologies and software). An 
analysis of the concentration ratio confirms that the higher 
concentration of patents in the high and low R&D-intensity 
groups compared to the medium R&D-intensity one is also 
found at firm level.27 
Revenues from licences issued 
and expenses for licences used
Figure 11 and Figure 12 compare KETS to other technologies 
in terms of revenue from licences issued and expenses for 
licences used by technology group. It should be noted that 
the response rate to this question is only half or less of the 
sample and thus considerably lower that of the previous 
sections.
27  The values of the standardised Herfindahl–Hirschman index (HHI) and of the 
concentration ratio (C4) are higher among high (HHI=0.293, C4=0.852) and low 
(HHI=0.212, C4=0.805) R&D intensity firms than among medium (HHI=0.068, 
C4=0.505) R&D intensity firms. If we look at the overall level of concentration, this is 
quite low when it comes to reported filed KETs patents (HHI: 0.083), although 51.6%of 
them were filed by only 5 firms.
Figure 11: Revenue from licenses
Note: The figure refers to 85 out of the 186 EU companies in the sample.
Source: European Commission JRC-IPTS (2014)
Figure 12: Expenses for licenses
Note: The figure refers to 93 out of the 186 EU companies in the sample.
Source: European Commission JRC-IPTS (2014)
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Figure 13: Revenue from licenses – detailed
Note: The figure refers to 87 out of the 186 EU companies in the sample.
Source: European Commission JRC-IPTS (2014)
Figure 14: Expenses for licenses – detailed 
Note: The figure refers to 81 out of the 186 EU companies in the sample.
Source: European Commission JRC-IPTS (2014)
The picture for licence revenues and expenses is similar to 
the observations on R&D invested by technological group and 
opposite to the above observations for patents. For licence 
revenues and expenses, socially and economically relevant 
technologies are more important than the others. For both 
licence revenues and expenses, other technologies represent 
a very small percentage of the total amounts, especially in 
the medium and low R&D intensity sectors. Only in the case 
of revenue from licenses for high R&D-intensity firms they 
reach a 2 digit figure (14 %). 
A more detailed look at licence revenues and expenses for 
each technology field is provided in Figure 13 and Figure 14 
below.
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For both licence revenues and expenses, high R&D-intensity 
firms have the lion’s shares (95 % of reported revenue and 87 
% for expenses). Licenses in red and green biotechnology are 
alone generating almost three quarters (73 %) of the reported 
revenue among the respondents. Other (red and green) 
biotechnology is the technology generating the majority of 
revenue for both high and medium R&D-intensity firms (75 % 
and 52 %, respectively), compared to key software 
technologies for the low R&D-intensity firms (78 %). 
Licence expenses follow a similar pattern as revenue. Also in 
this case, other (red and green) biotechnology constitute the 
majority of expenses (65 % of the total amount reported), 
both for firms belonging to the high and medium R&D-
intensity sectors (63 % and 95 % respectively). Licence 
expenditures from low R&D-intensity companies are instead 
concentrated in key software technologies (90 %). Just as in 
patents, the concentration of licence revenue and expenses 
is confirmed also at the firm level.28
28  We computed the values of the HHI and C4 ratio also for revenue from KETs 
licences issued and expenses for KETs licences used. Revenue is more concentrated 
than expenses for companies in the high (HHI=0.66 for revenue against HHI=0.33 
for expenses) and low (HHI=0.47 for revenue against HHI=0.39 for expenses) R&D 
intensity sectors. The opposite is true for companies in the medium R&D intensity 
sector (HHI=0.35 for revenue against HHI=0.87 for expenses). The overall values of the 
C4 ratio confirm the high concentration of reported revenue from (0.92) and expenses 
for (0.95) KETs licenses. 
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This survey collects information about the location of R&D 
by world region by addressing both the current distribution 
(stock) of R&D investment and the distribution of the 
expected changes in R&D investment (dynamics). The current 
distribution in terms of shares of total R&D investment in 
each of the seven world regions is displayed in Figure 15 
below.
The EU-based companies in the sample carry out one-fifth 
of their R&D outside the EU (21 %), which is very similar to 
the findings of our three previous surveys. The largest share 
of R&D investment outside the EU is in the United States 
and Canada (8.4 %), followed by China (4.3 %), the rest of 
the world (3.6 %), India (1.9 %), other European countries 
(1.6 %) and Japan (1.2 %). 
Another finding very similar to those of our previous 
surveys is the observation that the combined share of R&D 
investment carried out in China and India is around 6 %. 
Considering those countries’ rising share of global production 
and GDP, their share of R&D investment by EU companies 
is steadily increasing, but it remains at a low level overall 
for the European companies surveyed. For China, a recent 
study observed a drop in its unusually high rates of growth 
in R&D expenditure to levels about three to four times that 
of developed economies such as the United States.29 The 
differences can still be explained by growth in GDP and the 
fact that China is investing strongly in technologies to help it 
progress beyond cost-based production.
29  ‘The Battelle 2014 Global R&D Funding Forecast’, R&D Magazine, December 2013 
(see: http://battelle.org/media/press-releases/2014-global-funding-forecast).
4 R&D Investment Location
Figure 15: Distribution of R&D investment by world region and sector group
Note:  The figure refers to 166 out of the 186 EU companies in the sample, weighted by R&D investment. Other EU countries include Switzerland, 
Norway and others, while the rest of the world includes a heterogeneous set of countries such as South Korea, Taiwan, and Brazil..
Source: European Commission JRC-IPTS (2014)
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The distribution in location of R&D investment by sector 
group is also similar to that seen in previous surveys. The 
sector with medium R&D intensity accounts for the largest 
share of R&D investment within the EU (86.2 %), mainly 
due to companies from the automobiles and parts sector. 
Companies in sectors with high R&D intensity, where Europe 
is already under-represented in relation to the United 
States,30 are the most internationalised companies outside 
the EU. They invest 15 % of their R&D in the United States 
30  In the Scoreboards, the R&D investment share of sectors with high R&D intensity 
is almost twice that of the EU for US companies, mainly due to pharmaceuticals and 
biotechnology and information and communications technology-related sectors (see 
the 2013 EU R&D Investment Scoreboard).
and Canada, which, as in most of our previous surveys, is 
mainly due to companies in two sectors – pharmaceuticals 
and biotechnology and technology hardware and equipment. 
Figure 16 below reveals the expectations for R&D investment 
growth in the different world regions by sector group for the 
overall average of 4.2%.
Figure 16:  Expected changes in R&D investment in the next three years, per annum, in real terms, by world 
region and sector group
 
Note:  The figure refers to 151 out of the 186 EU companies in the sample, weighted by R&D investment and after elimination of outliers. Other EU 
countries include Switzerland, Norway and others, while the rest of the world includes a heterogeneous set of countries such as South Korea, 
Taiwan, and Brazil.
Source: European Commission JRC-IPTS (2014)
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The distribution in expectations for growth is similar to that 
observed in our previous surveys. Growth in R&D investment 
is expected to be relatively low in the EU (3.1 % per year over 
the next three years). 
Much higher growth is expected in the non-EU world regions: 
India (11.9 %); China (8.7 %); the United States and Canada 
(8.1 %); and the rest of the world (7.2 %). Expectations for 
Japan and other European countries lie at around 1 % or 
below and are combined with a relatively small share in total 
R&D investment, which makes the results for those countries 
more sensitive to bias from sample composition. 
In sectors with high R&D intensity, pharmaceuticals and 
biotechnology and software and computer services are 
the drivers of increases in R&D investment in the United 
States and Canada and India. The declining increases in 
R&D investment in sectors with high R&D intensity in China 
are due to a mixed picture, with some pharmaceuticals and 
biotechnology companies expecting increases and others 
decreases. For R&D investment in sectors with medium 
R&D intensity in the EU, slightly positive expectations in the 
automobiles and parts sector are offset by slightly negative 
ones in the chemicals and industrial engineering sector. 
The realisation of the above expectations would lead to a 
future reduction in EU countries’ share of R&D investment. 
In parallel, the shares of R&D invested in the United States 
and Canada, China, India and the rest of the world would 
increase (Figure 17).
Figure 17: R&D investment shares in 2013 and expected in 2016, by world region 
 
Note:  The figure refers to 151 out of the 172 EU companies in the sample, weighted by R&D investment and after elimination of outliers. Other EU 
countries include Switzerland, Norway and others, while the rest of the world includes a heterogeneous set of countries such as South Korea, 
Taiwan, and Brazil.
Source: European Commission JRC-IPTS (2014)
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Such higher expectations for R&D investment growth 
outside the EU have been observed in five of our seven 
previous surveys. As these expectations were within similar 
dimensions,31 this can be considered a trend. The patterns 
were always similar, with the highest growth rates expected 
for China and India, followed by the United States and 
Canada, while other world regions remained at more modest 
levels. 
It should be pointed out that the above picture of a decreasing 
relative share being invested in R&D in the EU occurs within 
the context of overall increases in the absolute amounts 
invested in R&D in all world regions. The anticipated nominal 
increases in investment in R&D in the EU are of a similar 
magnitude to those outside the EU (around € 900 million 
per year over the next three years). In other words, R&D 
investment growth is not expected to continue to follow 
the present distribution, but in future about half the R&D 
31 The only exception was the 2008 survey, where R&D investment was expected to 
stagnate owing to the impact of the economic and financial crisis in autumn 2008.
investment will be inside the EU and the other half outside. 
This has also been observed in our previous surveys, and it 
reflects the increasing participation of European companies 
in the global economy, and in particular in emerging 
economies, while they retain their R&D focus inside the EU. 
It also indicates that the gap between R&D invested by the 
surveyed companies in the EU and in countries such as China 
and India has not widened significantly. 
A few companies from the pharmaceuticals and biotechnology 
sector provided comments revealing substantial efforts 
to redistribute their global R&D. These are in line with 
the results of a study presented at the recent Third IRIMA 
Workshop on the Internationalisation of Corporate R&D and 
Innovation, showing that multinational companies in that 
sector are involved in an ongoing process of restructuring 
their global R&D value.32 
32 Ramírez, P., 2014. Outsourcing and Offshoring of R&D in the Pharmaceutical 
Industry: Evidence and Policy Implications from a Global Value Chain Analysis, 
Birmingham Business School, Birmingham, UK (see: http://iri.jrc.ec.europa.eu/
documents/10180/247186/Ramirez_presenter_session%202).
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The above considerations on the geographical distribution of 
R&D investment are further addressed by country-specific 
questions on the most attractive location for R&D and 
through the potential for a pairwise country comparison of 
innovation-related factors for attractiveness. 
Countries considered the most 
attractive location for the 
company’s R&D
Respondents were asked to state the three countries currently 
considered the most attractive location for the company’s 
R&D. The most attractive country could be chosen freely, so 
these locations did not necessarily need to be actual R&D 
sites. The result of ranking the most attractive country for 
the company’s R&D is shown in Figure 18 below. 
5 Attractiveness of Countries for R&D
Figure 18: Most attractive countries for the company’s R&D
 
Note:  * Based on an attractiveness index for 161 responses out of the 186 companies in the sample: countries ranked as most attractive with 3 points, 
as 2nd most attractive with 2 points, and as 3rd most attractive with 1 point.* Based on an attractiveness index for 161 responses out of the 
186 companies in the sample: countries ranked as most attractive with 3 points, as 2nd most attractive with 2 points, and as 3rd most attrac-
tive with 1 point.
Source: European Commission JRC-IPTS (2014)
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Two-thirds of the respondents considered their home 
country among the most attractive locations. This is a very 
similar finding to that of our previous surveys.33 Finland and 
Denmark were mentioned only by respondents for which 
that country is the home country.
The United States, Germany, China and India are seen as 
the most attractive locations outside the home country. The 
Netherlands, Poland and Romania are EU countries with an 
especially high attractiveness index for companies for which 
they are not the home country. All the above observations 
were very similar compared with our previous four surveys.
33 As observed in the 2010 and 2008 surveys, more than two-thirds of the 
respondents considered their home country the most attractive location for R&D, 
whereas in the 2013 survey the proportion was exactly two-thirds.
Attractiveness of the two 
countries where the company 
has the greatest R&D activity
The respondents were also asked about the level of 
attractiveness of the two countries where they have the 
greatest R&D activity. This question allows for a pairwise 
comparison of the actual R&D locations. As might be 
expected from the observations above (about the most 
attractive location for the company’s R&D), 9 out of 10 
respondents stated their home country to be one of the two 
with the highest volume of R&D activity (Figure 19). 
The biggest EU countries and the United States are the 
countries in which the respondents have the highest volumes 
of R&D activity. They are followed by Italy, Sweden, Finland, 
Spain, and Denmark. A large proportion of companies that 
have their biggest R&D sites in Denmark, Spain, Italy, Austria 
and Finland are also headquartered in those countries. The 
opposite is true for the Netherlands, where the biggest R&D 
sites belong to companies headquartered outside, and for 
non-EU countries playing an important role in the expansion 
of R&D investment, such as China and India.
Figure 19: Countries where the company has the highest volumes of R&D activities
 
Note: The figure refers to 174 out of the 186 companies in the sample. Numbers of statements refer to one of the two countries where the company 
has the highest volume of R&D activities.
Source: European Commission JRC-IPTS (2014)
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As a follow-up, respondents were asked to rate a number 
of attractiveness factors for the countries where companies 
have the highest volumes of R&D activity (Figure 20).34   
As in our previous survey, above average attractiveness 
was attributed to R&D personnel in the labour market 
(quality, quantity and labour costs), knowledge-sharing and 
collaboration opportunities (with universities and public 
research organisations), proximity (to other company sites, 
technology poles and incubators, and suppliers), intellectual 
property rights (IPR) (in terms of enforcement conditions, 
34  Innovation is the introduction of new or significantly improved products, services 
or processes.
costs of protection and the time taken to obtain it), and 
demand for innovation in terms of market size. 
The quality and quantity of R&D personnel in the labour 
market clearly ranked ahead of labour costs. For the other 
factors that were not so influential for R&D attractiveness, 
public procurement and product market regulation were not 
deemed to make a country attractive for R&D. While public 
support for R&D was not particularly relevant on average, it 
seemed more relevant to the sector with low R&D intensity, 
whereas IPR issues were more relevant for the sectors with 
medium and high R&D intensity. 
Figure 20: Attractiveness factors of the two countries with the highest volume of R&D activities
 
Note:  The factors are grouped by the average relevance of the major items in the survey.  
The figure refers to 157 out of the 186 companies in the sample.
Source: European Commission JRC-IPTS (2014)
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Attractiveness of EU countries 
For the two countries where the company currently has 
the greatest R&D activity, this section addresses the 
attractiveness of 12 EU countries for which at least five 
statements were received.35 The non-EU countries for which 
35 Sorted by average attractiveness, these are the United Kingdom (20 statements 
were obtained), Germany (54), Finland (16), Spain (15), Belgium (10), France (25), 
Austria (7), Sweden (16), Italy (19), the Netherlands (10), Denmark (7) and Poland (6).
more than five responses were obtained are analysed in 
the next section.36 below shows the top three and the least 
attractive factor for each of the EU countries.
Table 2 below shows the top three and the least attractive 
factor for each of the EU countries.
36 The United States, China and India.
Table 2: Top three and lowest attractiveness factor for EU countries with at least five statements
country
(number of
statements)
average
rating
most
attractive
second most 
attractive
third most 
attractive least attractive
United Kingdom (20) 3,37 quality of R&D personnel
knowledge-sharing
opportunities with
universities & public
organisations
quantity of R&D 
personnel
innovation demand via
public procurement
Germany (54) 3,26 quality of R&D personnel proximity to other
company sites
knowledge-sharing
opportunities with
universities & public
organisations
public R&D support via
fiscal incentives
Finland (16) 3,26 quality of R&D personnel
knowledge-sharing
opportunities with
universities & public
organisations
proximity to other
company sites
time to obtain Intellectual
Property Rights protection
Spain (15) 3,24 quality of R&D personnel public R&D support via
fiscal incentives
knowledge-sharing
opportunities with
universities & public
organisations
innovation demand via
market growth
Belgium (10) 3,20 proximity to other
company sites
public R&D support via
grants & direct funding
knowledge-sharing
opportunities with
universities & public
organisations
innovation demand via
public procurement
France (25) 3,18 public R&D support via
fiscal incentives
quality of R&D personnel
proximity to other
company sites
innovation demand via
public procurement
Austria (7) 3,14
knowledge-sharing
opportunities with
universities & public
organisations
quality of R&D personnel
quantity of R&D 
personnel
innovation demand via
market growth
Sweden (16) 3,13 quality of R&D personnel
knowledge-sharing
opportunities with
universities & public
organisations
proximity to other
company sites and
technology poles &
incubators
innovation demand via
market growth
Italy (19) 3,02 quality of R&D personnel quantity of R&D personnel proximity to other
company sites
innovation demand via
market growth
The Netherlands (10) 3,00 quality of R&D personnel proximity to technology
poles & incubators
knowledge-sharing
opportunities with other
firms
innovation demand via
market growth
Denmark (7) 3,00 proximity to other
company sites
knowledge-sharing
opportunities with
universities & public
organisations
knowledge-sharing
opportunities with other
firms
innovation demand via
market size & growth
Poland (6) 2,89
labour costs of R&D
personnel
quality of R&D personnel
quantity of R&D 
personnel
public R&D support via
public-private
partnerships
Note:  Refers to 103  out of the 186 companies in the sample, numbers of statements per country in brackets ().
        Countries are sorted by average attractiveness.
Source: European Commission JRC-IPTS (2014)
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For these countries, the quality of R&D personnel (10 
statements) and knowledge-sharing opportunities with 
universities and public organisations (eight statements) 
were by far the most frequently found to be among the 
top three factors for attractiveness in these countries. They 
are followed by proximity to other company sites (Belgium, 
Denmark, Germany, France, Italy, Finland and Sweden) and 
quantity of R&D personnel (Italy, Austria, Poland and the 
United Kingdom). 
Public support for R&D was stated as being important for 
Spain (via fiscal incentives) and Belgium (via grants and 
direct funding) and knowledge-sharing opportunities with 
other firms for Denmark and the Netherlands. For Poland, 
all three human resources-related aspects (labour costs and 
quality and quantity of R&D personnel) are attractiveness 
factors. 
The factors that are the least attractive centre on demand 
for innovation via market growth (Denmark, Spain, Italy, the 
Netherlands, Austria and Sweden) and public procurement 
(Belgium, France and the United Kingdom). The lack of market 
growth for most of these 12 countries is not compensated 
for by the creation of demand via public procurement or 
product market regulation. 
Figure 21 on the next page shows the country ratings for the 
individual factors in more detail. 
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Attractiveness of EU countries 
versus the US
Considering the possibility for a pairwise comparison, Figure 
22 compares the attractiveness of the EU and the United 
States as either of the sites where the company has the 
highest volume of R&D activity.
Knowledge-sharing opportunities and quality and quantity of 
R&D personnel are the leading attractiveness factors for the 
EU and the United States, before proximity factors.
As in our previous survey, respondents considered the United 
States more attractive for R&D than the EU regarding market 
size and growth, whereas the quality of R&D personnel in the 
labour market and public R&D support, via grants and direct 
funding and fiscal incentives, stood out in EU countries. 
Figure 22: Attractiveness of EU countries compared to the US for 38 cases
 
Note: The figure refers to 38 out of the 186 companies in the sample. 
Source: European Commission JRC-IPTS (2014)
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Attractiveness of EU countries 
versus China and India
For 13 actual cases, Figure 23 compares the attractiveness 
of sites in EU countries with the greatest R&D activity with 
those in China and India with the second highest volume.
The pairwise comparison between these actual sites in the 
EU and in China and India reveals that the attractiveness 
factors are rather different between the two world regions. 
For actual R&D sites in the EU, quality of R&D personnel, 
knowledge-sharing opportunities (with universities and 
public organisations and other firms) and proximity (to 
other company sites, technology poles and incubators, and 
suppliers) are the most relevant factors. 
For actual R&D sites in China and India, market size and 
growth, together with the quantity and labour costs of R&D 
personnel, are determinants of attractiveness. Compared 
with the EU, China and India also lack attractiveness in 
terms of IPR factors (especially enforcement conditions) and 
public support for R&D in terms of grants and direct funding, 
public–private partnerships and financing other (non-R&D) 
investments. 
Figure 23: Attractiveness of EU countries versus China and India for 13 cases
 
Note:The figure refers to 13 out of the 186 companies in the sample. 
Source: European Commission JRC-IPTS (2014)
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Survey participants were asked to state which R&D efforts 
are important for innovation in their company.37 Given a 
selection of specific R&D activities, respondents could rank 
37 Innovation is the introduction of new or significantly improved products, services 
or processes.
them from 1 (irrelevant) to 5 (highly relevant). In order to 
compare the results, we report the proportion of respondents 
that rate these activities as relevant (4) or highly relevant (5) 
in relation to all respondents for each activity (Figure 24). 
6 R&D and Innovation 
Figure 24: Relevance of activities for the company’s innovations
 
Note:  The activities are listed by average relevance of the major items in the survey.  
The figure refers to 169 out of the 186 companies in the sample.
Source: European Commission JRC-IPTS (2014)
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Internal R&D activities are by far the most important 
factor for company innovation. On average, 97.2 % of the 
responding companies rate internal R&D as relevant or 
highly relevant. For companies from sectors with medium 
R&D intensity, this is the case for 98.8 % of the respondents, 
compared with those from sectors with high (98.0 %) and 
low R&D intensity (94.6 %). 
The second most relevant factor for innovation is market 
research, advertising and other marketing activities related 
to the introduction of a new product (average of 58.8 % for 
all three R&D intensity groups). This effort is more important 
for companies from sectors with medium R&D intensity 
(68.3 %) than those from sectors with high (63.5 %) or low 
R&D intensity (61.1 %).
Product demonstration follows in third position. On average, 
54.0 % of all respondents (combined for activities inside 
and outside the EU) state that this activity is relevant or 
highly relevant for their company’s innovation. Product 
demonstrations such as pilot lines and demonstrators 
are more important for firms in sectors with medium 
and low R&D intensity than for those from high-intensity 
sectors. However, firms in all sectors value utilising internal 
infrastructure (69.3 %) significant more highly than using 
third-party infrastructure (38.8 %).
Training to support innovation activities (average of 52.5 % 
for all three R&D intensity groups) is more important for 
companies from sectors with high R&D intensity (60.0 %) 
than for those from sectors with medium (51.8 %) or low 
R&D intensity (45.7 %).
R&D outsourced to public organisations is rated highest 
by firms in sectors with low R&D intensity, followed by the 
high-intensity sectors in second place and medium-intensity 
sectors last. Furthermore, those activities are significantly 
more important within the EU (51.4 %) than in non-EU 
countries (26.9 %).
Design is rated significantly higher by firms in sectors with 
medium R&D intensity than in high- and low-intensity 
sectors (50.0 % vs 42.3 % and 20.0 %, respectively).
Firms across all sector groups value the acquisition of new or 
significantly improved machinery, equipment and software 
within the EU more highly than acquiring the same goods 
from outside (non-EU) countries. This preference for internal 
acquisition is stronger for companies from sectors with high 
R&D intensity.
Although firms in sectors with low R&D intensity report 
the highest level of relevance for outsourcing to public 
organisations in non-EU countries, followed by those in high- 
and medium-intensity sectors, the picture changes when 
considering outsourcing to companies. Such outsourcing is 
very important for companies from sectors with high R&D 
intensity (45.3 %) but less relevant for those from low- 
(32.8 %) and medium-intensity sectors (21.1 %). 
Purchasing or licensing IPR and know-how is indicated as the 
least relevant factor for company innovation. It is, however, 
more important for innovation in firms in sectors with high 
R&D intensity (both from within and outside the EU, with a 
slight preference for intra-EU transactions). Companies from 
sectors with low and medium-high R&D intensity rate this 
factor as having lower relevance. Whereas firms with low 
R&D intensity prefer intra-EU activities, those with medium 
R&D intensity show a slight preference for activities in non-
EU countries.
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7 Annex A: The Methodology of 
the 2014 Survey
Background and Approach
In order to improve the understanding of industrial R&D and 
innovation in the EU and to identify medium and long-term 
policy implications, the European Commission established 
the Industrial Research and Innovation Monitoring and 
Analysis (IRIMA)38 initiative. IRIMA is carried out by the 
European Commission’s Joint Research Centre (JRC) - 
Institute for Prospective Technological Studies (IPTS) and 
the Directorate General for Research - Directorate A, Policy 
Development and Coordination. The project monitors and 
analyses industrial R&D and innovation activities in order to 
support the implementation and monitoring of the European 
research and innovation agenda (the Innovation Union 
flagship, set in the context of the Europe 2020 strategy 
aiming at a smarter, greener and more inclusive economy). 
The evidence gathered also contributes to policy-making in 
other relevant Europe 2020 flagship initiatives such as the 
“Industrial Policy”, the “Digital Agenda” and the “New Skills 
for New Jobs” ones. 
The IRIMA surveys tackles the lack of comparable 
information on business R&D investment trends at the 
European level by gathering qualitative information on 
factors and issues surrounding and influencing companies’ 
current and prospective R&D investment strategies. The 
survey complements other R&D investment related surveys 
and data collection exercises (e.g. Innobarometer, Eurostat 
data collection and other on-going surveys). 
38  See: http://iri.jrc.ec.europa.eu/. The rationale for the IRIMA activities emerged in 
the context of the European Commission’s “3% Action Plan” established to implement 
and monitor the 3% R&D investment intensity target of the Lisbon strategy (“Investing 
in research: an action plan for Europe” (COM, 2003)) and in further Communications 
of the Commission (“More Research and Innovation – Investing for Growth and 
Employment – A common approach”, COM (2005) 488 final, “Implementing the 
Community Lisbon Programme: A policy framework to strengthen EU manufacturing 
– Towards a more integrated approach for industrial policy”, COM (2005) 474 final). 
The activity is undertaken jointly by the Directorate General for Research (DG RTD A, 
see: http://ec.europa.eu/research/index.cfm) and the Joint Research Centre, Institute of 
Prospective Technological Studies (JRC-IPTS, see: http://ipts.jrc.ec.europa.eu/activities/
research-and-innovation/iri.cfm).
Link to the R&D Investment 
Scoreboards
As part of the Industrial Research and Innovation Monitoring 
and Analysis (IRIMA) initiative, the EU R&D surveys and 
complement the EU Industrial R&D Investment Scoreboard.39 
The Scoreboard is the main IRIMA product and serves as a 
tool for the European Commission to monitor and analyse 
company R&D investment trends, and to benchmark, inform 
and communicate developments in R&D investment patterns. 
While the Scoreboard is based on the audited annual 
accounts of companies and therefore looks at trends ex-post, 
the Survey improves the understanding of the Scoreboard 
companies by collecting (ex-ante) information. In addition 
to forward-looking issues, the survey addresses location 
strategies, drivers and barriers to research and innovation 
activities, or perception of policy support measures with a 
questionnaire agreed between JRC-IPTS and DG-RTD. This 
questionnaire is printed and mailed by post together with the 
Scoreboard analysis report and the previous Survey analysis 
report to the 1000 European companies. Also a web-
interface and email contacts are made available in order to 
allow for paperless participation. The Survey makes efficient 
use of the direct contacts established with the European 
Scoreboard companies by adding-on to the Scoreboard 
mailing when the reports are officially released. 
For the 2014 Survey, the response period ran for three and a 
half months from 19th March (mailing of the questionnaires) 
to 8th July 2014 (reception of the last response).
39  The Scoreboard is published annually and provides data and analysis on the 
largest R&D investing companies in the EU and abroad (see: http://iri.jrc.ec.europa.eu/
research/scoreboard.htm).
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Methodology 
To improve response rates, the following measures were 
taken in the course of the survey cycle:
(1) The questionnaire was revised and streamlined with a 
view towards keeping it as short and concise as possible 
and minimise the burden for the respondent. The 2014 
questionnaire had a smaller number of items compared 
to its predecessors due to the streamlined country 
comparisons in questions 7 and 8.
(2) The questionnaire was sent together with the Scoreboard 
report to take advantage of this occasion as a door-
opener. 
(3) The cover-letter presented a figure and table with a 
benchmarking analysis of the company addressed 
compared to its peers in the same sector.  
(4) As well as physically sending the questionnaire to each 
company, an online site was provided to facilitate 
data entry via the European Commission’s Interactive 
Policy-Making (IPM) tool,40 where a Word version of the 
questionnaire was downloadable for offline information 
input.
(5) The questionnaire was emailed to the respondents of 
previous surveys, together with a link to the electronic 
copy of the latest analysis.
(6) The contact database was continuously improved. 
Respondents who had already participated in previous 
surveys, or their substitutes in cases where they had 
left their position, were priority contacts. Returned 
questionnaires and reminder mailings were resent using 
the latest contact information on the internet or by 
contacting the company directly via email or phone.
(7) The response rate is closely followed on a regular basis 
during the implementation. If necessary, measures for 
improving the response rate are applied, e.g. by adjusting 
the number of reminders, allowing more time for 
questionnaire reception, following up selected candidates 
by e-mail and phone or searching support from former 
survey participants
(8) Personal contact by phone or email was made with 
several dozen companies when the deadlines were close, 
especially for those which had participated in the past.
The response rate has been steadily high over the past five 
years, taking full advantage of the familiarity of the EU 
40  See: http://ec.europa.eu/yourvoice/ipm/index_en.htm 
Scoreboard companies with the exercise and their mature 
approach41. 
Outliers were detected by analysing the distribution of 
the dataset in scatter and boxplots and defining upper and 
lower quartiles ranges around the median, according to the 
variable(s) analysed. To maintain the maximum information 
in the data, outliers were eliminated only in extreme cases 
and after assessing the impact on the result.42
One-year growth is simple growth over the previous 
year, expressed as a percentage: 1yr growth = 100*((C/B)-
1); where C = current year amount and B = previous year 
amount. 1yr growth is calculated only if data exist for both 
the current and previous year. At the aggregate level, 1yr 
growth is calculated only by aggregating those companies 
for which data exist for both the current and previous year.
Three-year growth is the compound annual growth 
over the previous three years, expressed as a percentage: 
3yr growth = 100*(((C/B)^(1/t))-1); where C = current year 
amount, B = base year amount (where base year = current 
year - 3), and t = number of time periods (= 3). 3yr growth is 
calculated only if data exist for the current and base years. 
At the aggregate level, 3yr growth is calculated only by 
aggregating those companies for which data exist for the 
current and base years.
Unless otherwise stated, the weighted figures presented in 
this report are weighted by R&D investment. 
41  The response rate of the present survey is 18.5%. This is slightly higher compared 
to the 17.2% of last year and similar to the previous three surveys (18.7% (2012), 
20.5% (2010) and 18.5% (2009)). The reason for the lower response rate in the last 
survey was in the shorter response period.
42  For the systematic detection of outliers, an adjusted methodology from the NIST/
SEMATECH e-Handbook of Statistical Methods was applied, see: http://www.itl.nist.gov/
div898/handbook/prc/section1/prc16.htm
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R&D Investment Definition 
The objective of the survey is to address R&D investment, 
and not R&D expenditure, due to its direct link to the 
Innovation Union headline target of 3% R&D-intensity for 
overall R&D investment of a country as a share of GDP. To 
make the survey as easy to complete as possible and to 
maximise the response rate, only a short definition of R&D 
investment, which is as close as possible to accounting 
standards, is provided in the survey.43 The definition refers 
mainly to R&D as reported in the company’s most recent 
accounts. The definition used in the survey is thus closely 
related to the International Accounting Standard (IAS) 38 
“Intangible Assets”,44 based on the OECD “Frascati” manual,45 
and the definition used in the EU Industrial R&D Investment 
Scoreboards.
  
Composition of the Responses
The 186 responses were classified according to the ICB46 
described in the questionnaire. Sector classifications 
of individual companies were cross-checked with the 
Scoreboards. In two cases, two respondents from the 
same company but different business units were received. 
It was decided to retain them in the sample as separate 
43  See Annex B
44  See http://www.iasplus.com/standard/ias38.htm 
45  See “Proposed Standard Practice for Surveys on Research and Experimental 
Development: Frascati Manual”, OECD, Paris, 2002, http://www1.oecd.org/publications/
e-book/9202081E.PDF 
46  ICB Industry Classification Benchmark (see: http://www.icbenchmark.com/docs/
ICB_StructureSheet_120104.pdf)
entities because they correspond to very large business 
units in different sub-sectors. In this sense, they could be 
considered to have similar decision-making authority within 
their business segment as if they were individual companies. 
The sectors were grouped according to their average R&D 
intensities in the Scoreboard as follows:
• High (more than 5%) R&D-intensity (58 companies): 
Pharmaceuticals & Biotechnology, Software & Computer 
Services, Aerospace & Defence, Technology Hardware & 
Equipment and Health Care Equipment & Services.
• Medium (between 2 and 5%) R&D-intensity (88 companies): 
Industrial Engineering, Chemicals, Electronic & Electrical 
Equipment, Automobiles & Parts, Food Producers, General 
Industrials, Fixed Line Telecommunications, Household 
Goods & Home Construction, Support Services, Media and 
Personal Goods.
• Low (less than 1%) R&D-intensity (40 companies): 
Construction & Materials, Industrial Metals & Mining, 
Banks, Electricity, Oil & Gas Producers, Gas, Water & 
Multi-utilities, Forestry & Paper, Mining, and Mobile 
Telecommunications.
Table 3 shows the distribution of the responses among the 
sectors with their respective R&D investment shares. 
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Most of the responses, both in terms of numbers of 
participants and share of R&D investment in the sample, 
were from the medium R&D-intensity sectors (see also 
Figure 3 of the section 2 R&D Investment Expectations). 
The number of responses by home country is shown in 
Table 4 below. According to the Scoreboard methodology, 
the home country is the country of registered office of the 
company. Similar to our previous surveys, most participants 
were from companies located in the three biggest Member 
States. 
Table 3: Distribution of the responses by sectors
ICB Sector Number of responses
Number of 
Scoreboard 
companies
Response 
rate by 
sector
Total R&D  investment 
share compared to the 
Scoreboard*
R&D 
intensity 
sector 
group**
Pharmaceuticals & Biotechnology 23 111 20.7% between 20 and 40 % High
Software & Computer Services 15 110 13.6% below 20 % High
Aerospace & Defence 8 23 34.8% below 20 % High
Technology Hardware & Equipment 8 46 17.4% between 20 and 40 % High
other high R&D-intensity sectors 4 44 9.1% High
Subtotal high R&D intensity 58 334 17.4% 26.0%
Industrial Engineering 23 112 20.5% between 20 and 40 % Medium
Chemicals 15 42 35.7% above 40 % Medium
Electronic & Electrical Equipment 11 76 14.5% below 20 % Medium
Automobiles & Parts 10 50 20.0% above 40 % Medium
Food Producers 7 27 25.9% between 20 and 40 % Medium
General Industrials 7 33 21.2% between 20 and 40 % Medium
Fixed Line Telecommunications 6 12 50.0% above 40 % Medium
Household Goods & Home Construction 5 19 26.3% between 20 and 40 % Medium
Other medium R&D intensity sectors 4 129 3.1%  Medium
Subtotal medium R&D intensity 88 500 17.6% 45.3%
Construction & Materials 9 42 21.4% below 20 % Low
Industrial Metals & Mining 7 15 46.7% below 40 % Low
Banks 6 9 66.7% below 20 % Low
Electricity 5 28 35.3% below 20 % Low
Other low R&D intensity sectors 12 69 17.4%  Low
Subtotal low R&D intensity 45 180 24.1% 31.9%
Total 172 1000 18.6% 36.4%
Note:  * For confidentiality reasons, R&D investment shares of individual sectors are shown in ranges and only shown for sectors with at least four 
responses.
** Sector group according to the average Scoreboard R&D-intensity of each sector.
Source: European Commission JRC-IPTS (2014)
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Figure 25 reveals that the average survey respondent is a very large company.47 However, there are differences in company 
size between the sector groups.
47  The average turnover of the responding companies was €13 billion, 34,000 employees, and 1,650 employees in R&D. Among the 186 respondents there were 7 medium-
sized and one small company mainly in the high R&D intensity sectors (according to the European Commission’s SME definition, see: http://ec.europa.eu/enterprise/enterprise_
policy/sme_definition/index_en.htm). Among the large companies in the sample, 23 had between 251 and 1,000 employees, 70 between 1,001 and 10,000 employees, 42 
between 10,001 and 30,000 employees, and 42 more than 30,000 employees.
Table 4: Distribution of the responses by home country of the company
country number of responses share of responses
Germany 39 21.0%
France 21 11.3%
UK 20 10.8%
Finland 17 9.1%
Italy 17 9.1%
Spain 14 7.5%
Sweden 13 7.0%
Belgium 9 4.8%
The Netherlands 9 4.8%
Denmark 8 4.3%
Austria 5 2.7%
Portugal 5 2.7%
other European countries* 9 4.8%
total 186 100%
Note:  For confidentiality reasons, only information for countries with at least four responses is shown. 
* including one company headquartered in a European non-EU country.Source: European Commission JRC-IPTS (2013)
Source: European Commission JRC-IPTS (2014)
Figure 25: Average turnover and employee numbers for the responding companies, by sector group
 
Note:  The activities are listed by average relevance of the major items in the survey.  
The figure refers to 169 out of the 186 companies in the sample.
Source: European Commission JRC-IPTS (2014)
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The numbers of average net sales and employees are 
inversely proportional to the R&D-intensity of the sector 
group. In other words, the higher the R&D-intensity of the 
sector group the smaller the average size of the companies 
in the sample. The average number of R&D employees of 
the companies surveyed is considerably larger in high and 
medium than in the low R&D-intensity sector. This is the 
result of the high share of R&D employees in large companies 
that responded from technology, hardware & equipment, 
pharmaceuticals & biotechnology and aerospace & defence 
(high R&D intensity), automobiles & parts, industrial 
engineering, and chemicals (medium R&D intensity) sectors. 
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Questionnaire on Business R&D Investment 
We would appreciate your response by (deadline), preferably by using the questionnaire at: (http://goo.
gl/HWKdrm). Alternatively, you may return this completed form by e-mail (Alexander.Tuebke@ec.europa.eu), 
fax (+34.95.448.83.26), or post48.
The information in your response will be treated as confidential. It will only be used within this study and in an 
aggregated form. The European Commission is committed to the protection and privacy of data49.    
It will take about 35 minutes to complete the questionnaire.
We will automatically inform you of the results of the survey when they are available (for that, please ensure 
that you have provided your e-mail address below). 
Name of the company you are responding for:  ____________________________________________________________
Its primary sectors of activity:  ____________________________________________________________
Your name:  ____________________________________________________________
Job title:  ____________________________________________________________
E-mail:  ____________________________________________________________
Phone number:  ____________________________________________________________
The European Commission may follow up this survey by short-interviews to clarify major trends revealed in the 
analysis. Please tick here ❏ if you do not wish to be approached for this purpose.  
Definition of R&D investment
For the purposes of this questionnaire, ‘R&D investment’ is the total amount of R&D financed by your 
company (as typically reported in its accounts). It does not include R&D financed from public sources. 
48  European Commission, Institute for Prospective Technological Studies (IPTS), Attn.: Alexander Tübke, Edificio Expo, Calle Inca Garcilaso 3, E-41092 Seville, Spain, Tel.: 
+34.95.448.83.80 
49  See the Privacy Statement on the last page
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A. Corporate background
1. How many employees in total have worked in your company in the past year (2013)?
 Around  ___________________________ (FTE50).
2. How many employees have worked on R&D in the company in the past year (2013)? 
 About   ___________________________ (FTE3).
B. R&D investment levels and trends
3. What was your R&D investment in the past year (2013)? 
 About € ___________________________ million.
4. At what average rate do you expect the company to change its overall R&D investment over the next three 
years (2014, 2015, 2016), in real terms?
 About   _____________________________ % per annum. 
50  Please indicate the number of employees on either permanent or fixed-term contracts in Full-Time Equivalents (FTE), with part-time employees included on a pro-rated basis 
in line with their contractual working hours.
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C. Key Enabling Technologies
5. The Commission is undertaking initiatives to strengthen certain Key Enabling Technologies (KETs) for the 
development of new goods and services.51 In the table below, please estimate the approximate numbers 
of patents filed, revenue from licences issued, expenses for licences used and amount of R&D for each 
technological field in the past year (2013).
number of 
patents filed
revenue 
from licences 
issued 
(million €)
expenses for 
licences used 
(million €)
amount 
of R&D 
investment 
(million €)
Key software technologies, e.g. high 
performance computing, building data value, social 
computing, internet-based applications, embedded 
systems, human-centred computing, enterprise 
applications and the generation of software-
intensive systems 
Micro- and nanoelectronics, e.g. semiconductor 
components and highly miniaturised electronics
Advanced materials leading to lower-cost 
substitutes of existing materials and new higher 
value-added products & services
Industrial (white) biotechnology applied to 
industrial processing and production of chemicals, 
materials and fuels
Other (red and green) biotechnology applied to 
medical and agricultural processes
Nanotechnology, i.e. design, production and 
application of structures, devices and systems by 
controllling shape & size at nanometric scale
Photonics, i.e. conversion of sunlight into 
electricity, photodiodes, LEDs and lasers
Advanced manufacturing technologies 
encompass the use of innovative technology to 
improve products or processes that drive innovation, 
including all production equipment that deploys a 
KET or any other innovative technology
Environmental technologies (incl. alternative 
energy), i.e. devices, materials, and techniques for 
pollution prevention, reduction or containment
Other technologies especially relevant for 
your company (please specify):
51  These Key Enabling Technologies (KETs) enable the development of new goods and services and the restructuring of industrial processes needed to modernise EU industry 
and make the transition to a knowledge-based and resource-efficient economy. Whilst the EU has very good R&D capacities in some KETs, it has not been as successful at 
translating research results into commercialised manufactured goods and services. The Commission’s KETs strategy aims to boost the industrial production of innovative of 
KETs-based products and applications of the future, see: http://ec.europa.eu/enterprise/sectors/ict/key_technologies/ 
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D. R&D location strategy
6. Please estimate the distribution of your company’s in-house R&D activity among the following world areas in 
the past year (2013) and three years later (2016)? 
Distribution in 2013 R&D carried out: Expected distribution in 2016
 % in the European Union52 %
% in other European countries53 %
% in the US and Canada %
% in Japan %
% in China %
% in India %
% in the Rest of the World %
7. Which countries do you currently consider the most attractive location for your company’s R&D? Please state 
the countries regardless whether your company has R&D activity there and rank by attractiveness.
1. _____________________________ 2. _____________________________ 3. _____________________________
52 53
52 There are currently 28 EU Member States: Austria, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, 
Italy, Latvia, Lithuania, Luxembourg, Malta, 
The Netherlands, Poland,  Portugal, Romania,  Slovakia, Slovenia, Spain, Sweden, and The United Kingdom.
53 Examples of other (non-EU) European countries are: Switzerland, Norway, Iceland, Albania, Moldova, Turkey, Russia, Belarus and the Ukraine (for further examples see the 
recognised states in: http://en.wikipedia.org/wiki/List_of_sovereign_states_and_dependent_territories_in_Europe#Recognised_states).
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8. Please state the two countries where your company currently has the highest volume of R&D activities:
A. ______________________________________________ B. ______________________________________________
How attractive are these two countries in terms of the following factors? Please rate on a scale from 1 (very low 
attractiveness) to 5 (very high attractiveness) and leave not-applicable factors blank.54 55
attractiveness of:
country A country B
very 
low
very 
high
very 
low
very 
high
1 2 3 4 5 1 2 3 4 5
(a) Demand for innovative goods & services:
(a1) market size
(a2) market growth
(a3) through public procurement
(a4) via product market regulation, norms & standards
£ 
£ 
£
£
£ 
£ 
£
£
£ 
£ 
£
£
£ 
£ 
£
£
£ 
£ 
£
£
£ 
£ 
£
£
£ 
£ 
£
£
£ 
£ 
£
£
£ 
£ 
£
£
£ 
£ 
£
£
(b) Human resources: 
(b1)  quality of R&D personnel in the labour          
market
(b2) quantity of R&D personnel in the labour market
(b3) labour costs of R&D personnel 
£
£
£
£
£
£
£
£
£
£
£
£
£
£
£
£
£
£
£
£
£
£
£
£
£
£
£
£
£
£
(c) Proximity to:
(c1) technology poles54 and incubators55
(c2) other company sites, e.g. production or sales
(c3) suppliers
£
£
£
£
£
£
£
£
£
£
£
£
£
£
£
£
£
£
£
£
£
£
£
£
£
£
£
£
£
£
(d)  Collaboration & knowledge-sharing opportunities:
(d1) with other firms
(d2) with universities and public research     
        organisations
£
£
£
£
£
£
£
£
£
£
£
£
£
£
£
£
£
£
£
£
(e) Public financial support for R&D via:
(e1) fiscal incentives
(e2) grants and direct funding
(e3) loans and guarantees
(e4) public-private partnerships
(e5) financing other (non-R&D) investments
£ 
£ 
£ 
£ 
£
£ 
£ 
£ 
£ 
£
£ 
£ 
£ 
£ 
£
£ 
£ 
£ 
£ 
£
£ 
£ 
£ 
£ 
£
£ 
£ 
£ 
£ 
£
£ 
£ 
£ 
£ 
£
£ 
£ 
£ 
£ 
£
£ 
£ 
£ 
£ 
£
£ 
£ 
£ 
£ 
£
(f) Intellectual Property Rights in terms of: 
(f1) costs of protection
(f2) time to obtain protection
(f3) conditions for putting them into force
£ 
£ 
£
£ 
£ 
£
£ 
£ 
£
£ 
£ 
£
£ 
£ 
£
£ 
£ 
£
£ 
£ 
£
£ 
£ 
£
£ 
£ 
£
£ 
£ 
£
Other (please specify):
_________________________________________________________________________________________
    _________________________________________________________________________________________
54 “Technology poles” are areas where R&D active companies, institutions and universitites are concentrated.
55 “Incubators” are structures that support innovative startup companies in order to increase their survival rates.
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E. R&D and innovation
How relevant are the following activities for your company’s innovations56? Please rate on a scale from 1 
(irrelevant) to 5 (highly relevant).
  
Irrelevant
Highly 
relevant
1 2 3 4 5
(a) R&D within the company £ £ £ £ £
(b) R&D outsourced to other companies: 
(b1) Inside the European Union 
(b2) In non-EU countries 
£ 
£
£ 
£
£ 
£
£ 
£
£ 
£
(c)  R&D outsourced to higher education institutions or public 
research organisations:
(c1) Inside the European Union 
(c2) In non-EU countries 
£ 
£
£ 
£
£ 
£
£ 
£
£ 
£
(d) Acquisition of new or highly improved machinery, equipment 
and software: 
(d1) Inside the European Union 
(d2) In non-EU countries 
£ 
£
£ 
£
£ 
£
£ 
£
£ 
£
(e) Purchase or licensing of Intellectual Property Rights 
(patents, copyrights and designs) as well as know-how:   
(e1) Inside the European Union 
(e2) In non-EU countries  
£ 
£
£ 
£
£ 
£
£ 
£
£ 
£
(f) Training to support innovative activities £ £ £ £ £
(g)  Design (graphic, packaging, process, product, service or 
industrial) £ £ £ £ £
(h) Market research, launch advertising, and related marketing 
activities for new product introduction:  
(h1) Inside the European Union 
(h2) In non-EU countries
£ 
£
£ 
£
£ 
£
£ 
£
£ 
£
(i) Product demonstration (pilot lines/demonstrators): 
(i1) Using internal infrastructure 
(i2) Using third-party infrastructure
£ 
£
£ 
£
£ 
£
£ 
£
£ 
£
Other (please specify):
____________________________________________________________________________________
F. Final comments or suggestions
_____________________________________________________________________________________
_______________________________________________________________________________________
_______________________________________________________________________________________
Thank you very much for your contribution!
56  Innovation is the introduction of new or significantly improved products, services, or processes.
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Privacy Statement
The 2014 EU Survey on R&D Investment Business Trends is carried out by the Industrial Research and Innovation 
(IRI) action of the European Commission’s Joint Research Centre (JRC), Institute for Prospective Technological 
Studies (IPTS). The survey is directed at the 1000 European companies in the 2013 EU Industrial R&D Investment 
Scoreboard.
The European Union is committed to data protection and privacy as defined in Regulation (EC) nº 45/2001. This survey is under 
the responsibility of the IRI action leader, Fernando Hervás Soriano, acting as the Controller as defined in the above regulation. 
The Controller commits himself dealing with the data collected with the necessary confidentiality and security as defined in the 
regulation on data protection and processes it only for the explicit and legitimate purposes declared and will not further process 
it in a way incompatible with these purposes. These processing operations are subject to a Notification to the Data Protection 
Officer (DPO) in accordance with Regulation (EC) 45/2001.
Purpose and data treatment
The purpose of data collection is to establish the analysis of the 2014 EU Survey of R&D Investment Business Trends. This 
survey has a direct mandate from the Commission’s 2003 Action Plan “Investing in Research” (COM 2003 (226) final, see http://
ec.europa.eu/invest-in-research/action/2003_actionplan_en.htm). The personal data collected and further processed are:
- Company: name, primary sectors of activity, company size
- Contact Person: name, job title, phone number, e-mail
The collected personal data and all information related to the above mentioned survey is stored on servers of the JRC-IPTS, the 
operations of which underlie the Commission’s security decisions and provisions established by the Directorate of Security for 
these kind of servers and services. The information you provide will be treated as confidential and aggregated for the 
analysis. 
Data verification and modification
In case you want to verify the personal data or to have it modified respectively corrected, or deleted, please write an e-mail 
message to the address mentioned under “Contact information”, by specifying your request. Special attention is drawn to the 
consequences of a delete request, in which case any trace to be able to contact you will be lost. Your personal data is stored as 
long as follow-up actions to the above mentioned survey are necessary with regard to the processing of personal data.
Contact information
In case you have questions related to this survey, or concerning any information processed in this context, or on your rights, feel 
free to contact the IRI Team, operating under the responsibility of the Controller at the following email address: jrc-ipts-iri@
ec.europa.eu.
Recourse
Complaints, in case of conflict, can be addressed to the European Data Protection Supervisor (EDPS) at www.edps.europa.eu.

European Commission
Joint Research Centre
Institute for Prospective Technological Studies (IPTS)
Contact information
European Commission
Joint Research Centre
Institute for Prospective Technological Studies
Edificio Expo
C/ Inca Garcilaso 3
E-41092 Seville (Spain)
Tel.: +34 95 448 83 18, Fax: +34 95 448 83 00
e-mail: jrc-ipts-secretariat@ec.europa.eu 
https://ec.europa.eu/jrc
Acknowledgements
“The 2014 EU Survey on Industrial R&D Investment Trends” has been published within the context of the 
Industrial Research and Innovation Monitoring and Analysis (IRIMA) activities that are jointly carried out by 
the European Commission’s Joint Research Centre (JRC) - Institute for Prospective Technological Studies 
(IPTS) and the Directorate General for Research - Directorate A, Policy Development and Coordination.
IRMA activities aim to improve the understanding of industrial R&D and Innovation in the EU and to identify 
medium and long-term policy implications. 
The project was coordinated under the leadership of Xabier Goenaga Beldarraín (Head of JRC-IPTS 
Knowledge for Growth - KfG Unit) and Román Arjona Gracia (Head of DG RTD.A4 Analysis and monitoring 
of national research policies). This document was produced by Alexander Tübke, Fernando Hervás, Jörg 
Zimmermann and Nicola Grassano (KfG Unit) as the main authors. Héctor Hernández, Sara Amoroso, Mafini 
Dosso, Antonio Vezzani and Iulia Siedschlag from the KfG Unit, Diana Ivanova van Beers from DG RTD.A, 
Anca Dumitrescu and Daniel Deybe from RTD.F, Sabine Prevost from RTD.D, and Nathalie Pasquier from 
GROW.H made contributions to the design and review of the survey. 
The JRC-IPTS and DG RTD-A would like to express their thanks to everyone who has contributed to this 
project.
Any comments can be sent by email to: JRC-IPTS-IRI@ec.europa.eu 
More information, including activities and publications, is available at: http://iri.jrc.es/ and http://ec.europa.eu/
research/index.cfm?lg=en
Legal Notice
This publication is a Science and Policy Report by the Joint Research Centre, the European Commission’s 
in-house science service. It aims to provide evidence-based scientific support to the European policy-making 
process. The scientific output expressed does not imply a policy position of the European Commission. 
Neither the European Commission nor any person acting on behalf of the Commission is responsible for the 
use which might be made of this publication.
All images © European Union 2014
JRC92349
EUR 26909 EN
ISBN 978-92-79-43964-3 (pdf), ISBN 978-92-79-43965-0 (print)
ISSN 1831-9424 (online), ISSN 1018-5593 (print)
doi:10.2791/14520
Luxembourg: Publications Office of the European Union, 2014
© European Union, 2014
Reproduction is authorised provided the source is acknowledged
European Commission
EUR 26909 EN - Joint Research Centre - Institute for Prospective Technological Studies - DG Research
Title: EU R&D SURVEY. The 2014 EU Survey on Industrial R&D Investment Trends
Author(s): Alexander Tübke, Fernando Hervás, Jörg Zimmermann and Nicola Grassano 
Luxembourg: Publications Office of the European Union
2014 - 52 pp. - 21.0 x 29.7 cm
EUR – Scientific and Technical Research series – ISSN 1831-9424 (online), ISSN 1018-5593 (print)
ISBN 978-92-79-43964-3 (pdf), ISBN 978-92-79-43965-0 (print)
doi:10.2791/14520
Abstract
This report presents the findings of the ninth survey on trends in industrial R&D investment. It analyses the 186 responses of 
mainly large firms from a subsample of 1000 EU-based companies in the 2013 EU Industrial R&D Investment Scoreboard. 
These 186 companies are responsible for R&D investment worth almost €60 billion, constituting around 36% of the total R&D 
investment by the 1000 EU Scoreboard companies.
The main conclusion is that the responding companies expect R&D investment to increase by on average 4.2 % per year during 
2014–16. This is about 50 % higher than the increase anticipated in the previous survey (2.6 %) and mainly reflects the shift in 
expectations in the automobiles and parts sector, which returns to the level of previous years (4.6 %) after last year’s reported 
stagnation (–0.4 %). 
The responding companies carry out one fifth of their R&D outside the EU. The responding companies’ expectations for R&D 
investment for the next three years show the ongoing participation of European companies in the global economy. While 
maintaining the focus of their R&D investment in the EU, they reap opportunities for growth in emerging economies. Two out 
of three of the responding EU-based companies consider their home country the most attractive location for R&D. The United 
States, Germany, China and India are the most attractive locations mentioned outside the home country.
LF-NA-26909-EN-N
EU R&D SURVEY
The 2014 EU Survey
on Industrial R&D
Investment Trends
Report EUR 26909  ENdoi:10.2791/14520
ISBN 978-92-79-43964-3
As the Commission’s 
in-house science service, 
the Joint Research Centre’s 
mission is to provide EU 
policies with independent, 
evidence-based scientific 
and technical support 
throughout the whole 
policy cycle.
Working in close 
cooperation with policy 
Directorates-General, 
the JRC addresses key 
societal challenges while 
stimulating innovation 
through developing 
new methods, tools 
and standards, and sharing 
its know-how with 
the Member States, 
the scientific community 
and international partners.
Serving society
Stimulating innovation
Supporting legislation
JRC Mission
